June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Developmental Progression of X-Linked Retinoschisis in Mouse Rods
Author Affiliations & Notes
  • Matthew Jacob Tarchick
    Biology, University of Akron, Akron, Ohio, United States
  • Craig Beight
    Research Service, Louis Stokes VA Medical Center, Cleveland, Ohio, United States
    Ophthalmology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Neal Peachey
    Research Service, Louis Stokes VA Medical Center, Cleveland, Ohio, United States
    Ophthalmology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, United States
  • Jordan Renna
    Biology, University of Akron, Akron, Ohio, United States
  • Footnotes
    Commercial Relationships   Matthew Tarchick None; Craig Beight None; Neal Peachey None; Jordan Renna None
  • Footnotes
    Support  R01 EY029796; P30 EY025585; RPB (Research to Prevent Blindness)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2606 – F0489. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Matthew Jacob Tarchick, Craig Beight, Neal Peachey, Jordan Renna; Developmental Progression of X-Linked Retinoschisis in Mouse Rods. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2606 – F0489.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : X-linked Retinoschisis (XLRS) is an early onset degenerative retinal disease that causes cystic lesions in the middle layers of the retina, a loss of visual acuity, and decreased contrast sensitivity. XLRS is caused by mutations in Retinoschisin 1 (RS1) which encodes the secreted protein retinoschisin (RS1). Rs1-mutant mouse models develop key hallmarks of XLRS including intraretinal schisis and reduced ERG b-waves. The disease phenotype is present at early ages leading to the question of whether retinal development is ever normal. Here we explore the early ERG properties of Rs1 mutant mice, using an ex vivo system and pharmacological blockade to isolate ERG components generated by photoreceptors, depolarizing bipolar cells (DBCs) and Müller glial cells (MGCs).

Methods : We recorded light evoked responses from WT and two Rs1-mutant strains Rs1KO, Rs1C59S at P13, an age where Rs1 mutants have developed intraretinal schisis. After dark adaptation, mice were sacrificed and retinae were isolated and mounted on a custom ERG chamber. ERGs were evoked by 1-4 ms pulses from a LED band-passed at 505±20 nm in triplicate. Photon intensity was varied from 5-50,000 photons/um-2. ERGs were recorded while retinae perfused by normal Ringers, Ringers contains barium chloride (100 µM) and then also LAP-4 (14 µM). Response components reflecting MGCs and DBCs were estimated by waveform subtraction.

Results : In comparison to WT, ERGs of Rs1 mutant mice had comparable b-waves, and a tendency toward larger a-waves, while MGC responses were only larger in Rs1C59S mice.

Conclusions : These results indicate that Rs1 mutations have less impact on the rod pathway at P13 than at later ages. Ongoing studies will determine the ERG phenotype at still younger ages.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×